Ann Knight

In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

Lindberg, Hanna; Knight, Ann; Hellbacher, Erik; Norling, Olof et al.

Part of ACR Open Rheumatology, 2025

• DOI for In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes
• Download full text (pdf) of In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Lundtoft, Christian; Knight, Ann; Meadows, Jennifer; Karlsson, Åsa et al.

Part of RMD Open, 2024

• DOI for The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population
• Download full text (pdf) of The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Sejersen, Kristina; Weitoft, Tomas; Knight, Ann; Lysholm, Jörgen et al.

Part of Rheumatology, 2023

• DOI for Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis
• Download full text (pdf) of Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

Antovic, A.; Bruchfeld, A.; Ekland, J.; Lovstrom, B. et al.

Part of Scandinavian Journal of Rheumatology, p. 418-423, 2023

• DOI for Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis
• Download full text (pdf) of Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden

Bower, Hannah; Frisell, Thomas; di Giuseppe, Daniela; Delcoigne, Benedicte et al.

Part of RMD Open, 2023

• DOI for Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden
• Download full text (pdf) of Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden

In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

Lindberg, Hanna; Knight, Ann; Hellbacher, Erik; Norling, Olof et al.

Part of ACR Open Rheumatology, 2025

• DOI for In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes
• Download full text (pdf) of In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides Identifies Distinct Clinical Phenotypes

The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Lundtoft, Christian; Knight, Ann; Meadows, Jennifer; Karlsson, Åsa et al.

Part of RMD Open, 2024

• DOI for The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population
• Download full text (pdf) of The HLA region in ANCA-associated vasculitis: characterisation of genetic associations in a Scandinavian patient population

Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Sejersen, Kristina; Weitoft, Tomas; Knight, Ann; Lysholm, Jörgen et al.

Part of Rheumatology, 2023

• DOI for Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis
• Download full text (pdf) of Serum calprotectin correlates stronger with inflammation and disease activity in ACPA positive than ACPA negative rheumatoid arthritis

Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

Antovic, A.; Bruchfeld, A.; Ekland, J.; Lovstrom, B. et al.

Part of Scandinavian Journal of Rheumatology, p. 418-423, 2023

• DOI for Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis
• Download full text (pdf) of Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden

Bower, Hannah; Frisell, Thomas; di Giuseppe, Daniela; Delcoigne, Benedicte et al.

Part of RMD Open, 2023

• DOI for Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden
• Download full text (pdf) of Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk?: A comparative effectiveness study of b/tsDMARDs in Sweden

Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study

Molina, Berengere; Padoan, Roberto; Urban, Maria Letizia; Novikov, Pavel et al.

Part of Annals of the Rheumatic Diseases, p. 1587-1593, 2023

• DOI for Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study

Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis

Ekman, Diana; Sennblad, Bengt; Knight, Ann; Karlsson, Åsa et al.

Part of Rheumatology, p. 3213-3218, 2023

• DOI for Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis
• Download full text (pdf) of Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis

High levels of interleukin-6 in rheumatoid arthritis joint fluids can stimulate local production of C-reactive protein resulting in elevated circulating levels

Rönnelid, Johan; Knight, Ann; Lysholm, Jörgen; Manivel, Vivek Anand et al.

Part of Joint Bone Spine, 2021

• DOI for High levels of interleukin-6 in rheumatoid arthritis joint fluids can stimulate local production of C-reactive protein resulting in elevated circulating levels

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Sattui, Sebastian E.; Conway, Richard; Putman, Michael S.; Seet, Andrea M. et al.

Part of The Lancet Rheumatology, 2021

• DOI for Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis with Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study

Lindberg, Hanna; Colliander, Caroline; Nise, Lena; Dahlqvist, Johanna et al.

Part of Journal of Rheumatology, p. 894-897, 2021

• DOI for Are Farming and Animal Exposure Risk Factors for the Development of Granulomatosis with Polyangiitis? Environmental Risk Factors Revisited: A Case-control Study

Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA

Dahlqvist, Johanna; Ekman, Diana; Sennblad, Bengt; Kozyrev, Sergey V. et al.

Part of Rheumatology, p. 3461-3470, 2021

• DOI for Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA
• Download full text (pdf) of Identification and Functional Characterization of a Novel Susceptibility Locus for Small Vessel Vasculitis with MPO-ANCA

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

Hellbacher, Erik; Hjorton, Karin; Backlin, Carin; Enblad, Gunilla et al.

Part of Acta Oncologica, p. 1655-1659, 2019

• DOI for Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis

A case of systemic lupus erythematosus with C1q deficiency, increased serum interferon-a levels and high serum interferogenic activity

Bolin, Karin; Eloranta, Maija-Leena; Kozyrev, Sergey V.; Dahlqvist, Johanna et al.

Part of Rheumatology, p. 918-919, 2019

• DOI for A case of systemic lupus erythematosus with C1q deficiency, increased serum interferon-a levels and high serum interferogenic activity

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Lyons, Paul A.; Peters, James E.; Alberici, Federico; Liley, James et al.

Part of Nature Communications, 2019

• DOI for Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
• Download full text (pdf) of Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status

Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis

Sohrabian, Azita; Mathsson Alm, Linda; Hansson, Monika; Knight, Ann et al.

Part of Annals of the Rheumatic Diseases, p. 1345-1353, 2018

• DOI for Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis
• Download full text (pdf) of Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis

Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies

Weitoft, Tomas; Larsson, Anders; Saxne, T; Manivel, Vivek Anand et al.

Part of Scandinavian Journal of Rheumatology, p. 346-352, 2017

• DOI for Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies

Malignant Lymphoma In Granulomatosis With Polyangiitis

Hellbacher, Erik; Hjorton, Karin; Sundström, Christer; Baecklund, Eva et al.

Part of Rheumatology, 2017

Number Of Peptide-Specific Anti-Citrullinated Peptide Antibodies In Synovial Fluid And In Synovial Fluid Immune Complexes Associate With Degree Of Radiological Destruction And Response To Triamcinolone Hexacetonide For Knee Synovitis In Rheumatoid Arthritis

Sohrabian, Azita; Mathsson Alm, Linda; Hansson, M.; Lysholm, J. et al.

Part of Annals of the Rheumatic Diseases, p. 509-510, 2017

• DOI for Number Of Peptide-Specific Anti-Citrullinated Peptide Antibodies In Synovial Fluid And In Synovial Fluid Immune Complexes Associate With Degree Of Radiological Destruction And Response To Triamcinolone Hexacetonide For Knee Synovitis In Rheumatoid Arthritis

Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

Knight, Ann; Pauksen, Karlis; Nordmark, Gunnel; Eva, Kumlien

Part of Rheumatology, p. 855-856, 2017

• DOI for Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab

A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

Chatzidionysiou, Katerina; Turesson, Carl; Teleman, Annika; Knight, Ann et al.

Part of RMD Open, 2016

• DOI for A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission
• Download full text (pdf) of A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission

Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Hertzell, Katarina Brodin; Pauksens, Karlis; Rombo, Lars; Knight, Ann et al.

Part of Vaccine, p. 650-655, 2016

• DOI for Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study

Late-onset neutropenia after rituximab in ANCA-associated vasculitis

Knight, Ann; Sundström, Y.; Börjesson, O.; Bruchfeld, A. et al.

Part of Scandinavian Journal of Rheumatology, p. 404-407, 2016

• DOI for Late-onset neutropenia after rituximab in ANCA-associated vasculitis

Lymphoma in Patients with Granulomatosis with Polyangiitis

Hjorton, Karin; Hellbacher, Erik; Sundstrom, Christer; Baecklund, Eva et al.

Part of Arthritis & Rheumatology, 2015

• DOI for Lymphoma in Patients with Granulomatosis with Polyangiitis

Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies

Weitoft, Tomas; Larsson, Anders; Manivel, Vivek A; Lysholm, Jörgen et al.

Part of Rheumatology, p. 1923-1928, 2015

• DOI for Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies

Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Knight, Ann; Hjorton, Karin; Sundström, Christer; Höglund, Martin et al.

Part of Journal of Rheumatology, p. 690-694, 2015

• DOI for Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.

Knight, A; Hallenberg, H; Baecklund, Eva

Part of Clinical Rheumatology, p. 841-848, 2014

• DOI for Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.
• Download full text (pdf) of Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis-a case series.

Late-onset neutropaenia in ANCA-associated vasculitis after rituximab treatment

Knight, Ann; Bruchfeld, A.; Gunnarsson, I.

Part of Scandinavian Journal of Rheumatology, p. 50-51, 2014

Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis: a prospective cohort study

Weitoft, Tomas; Rönnelid, Johan; Knight, Ann; Lysholm, Jörgen et al.

Part of Arthritis Research & Therapy, 2014

• DOI for Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis: a prospective cohort study
• Download full text (pdf) of Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis: a prospective cohort study

Scalp necrosis as a late sign of giant-cell arteritis

Alimohammadi, Mohammad; Knight, Ann

Part of Case reports in immunology, 2013

• DOI for Scalp necrosis as a late sign of giant-cell arteritis

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

Nordström, Dan; Knight, Ann; Luukkainen, Reijo; van Vollenhoven, Ronald et al.

Part of Journal of Rheumatology, p. 2008-2011, 2012

• DOI for Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission

Chatzidionysiou, Katerina; Turesson, Carl; Teleman, Annika; Knight, Ann et al.

Part of Arthritis and Rheumatism, 2012

Occupational risk factors for Wegener's granulomatosis: a case-control study

Knight, Ann; Sandin, Sven; Askling, Johan

Part of Annals of the Rheumatic Diseases, p. 737-740, 2010

• DOI for Occupational risk factors for Wegener's granulomatosis: a case-control study

Increased Risk of Autoimmune Disease in Families with Wegener's Granulomatosis

Knight, Ann; Sandin, Sven; Askling, Johan

Part of Journal of Rheumatology, p. 2553-2558, 2010

• DOI for Increased Risk of Autoimmune Disease in Families with Wegener's Granulomatosis

What is the significance in routine care of c-ANCA/PR3-ANCA in the abscence of systemic vasculitis?: A case series

Knight, Ann; Ekbom, Anders; Brandt, Lena; Askling, Johan

Part of Clinical and Experimental Rheumatology, 2008

Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease

Knight, Ann; Sandin, Sven; Askling, Johan

Part of Arthritis and Rheumatism, p. 302-7, 2008

• DOI for Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease

Increasing Incidence of Wegener´s granulomatosis in Sweden 1975-2001

Knight, Ann; Ekbom, Anders; Brandt, Lena; Askling, Johan

Part of Journal of Rheumatology, p. 2060-2063, 2006

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide

Knight, Ann; Askling, Johan; Fredrik, Granath; Pär, Sparen et al.

Part of Annals of the Rheumatic Diseases, p. 1307-1311, 2004

• DOI for Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide

Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis

Turesson, C.; Börjesson, O.; Larsson, K.; Mohammad, A. J. et al.

Part of Scandinavian Journal of Rheumatology, p. 259-265, 2019

• DOI for Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis
• Download full text (pdf) of Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis

Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

Kaiser, Christina; Knight, Ann; Nordström, Dan; Pettersson, Tom et al.

Part of Rheumatology International, p. 295-299, 2012

• DOI for Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

Clinical and Epidemiological Studies of Wegener´s Granulomatosis

Knight, Ann

2007

• Download full text (pdf) of Clinical and Epidemiological Studies of Wegener´s Granulomatosis